GLOBAL BLOOD THERAPEUTICS, INC. Item 5.07 Submission of Matters to a Vote of Security Holders.
The proposals set forth below were submitted to the stockholders at the 2021
Annual Meeting of Stockholders, or Annual Meeting, of
The number of shares of common stock entitled to vote at the Annual Meeting was 62,266,753. The number of shares of common stock present or represented by valid proxy at the Annual Meeting was 45,159,323. The number of votes cast for and against and the number of abstentions and broker non-votes with respect to each proposal voted upon are set forth below.
Proposal 1 - Election of Directors
The Company's stockholders elected the Class III director nominees below to the Company's Board of Directors to hold office until the 2024 Annual Meeting of Stockholders or until their successors are duly elected and qualified.
Director Nominee Votes For Votes Withheld Scott W. Morrison 29,333,509 10,668,327 Deval L. Patrick 28,898,519 11,103,317 Mark L. Perry 29,322,421 10,679,415
There were 5,157,487 broker non-votes regarding this proposal.
Proposal 2 - Approval, on a Non-Binding, Advisory Basis, of the Compensation of the Company's Named Executive Officers as Disclosed in the Proxy Statement
The Company's stockholders did not approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.
Votes For Votes Against Abstentions 17,805,541 22,152,973 43,322
There were 5,157,487 broker non-votes regarding this proposal.
Proposal 3 - Ratification of Appointment of Independent Registered Accounting Firm
The Company's stockholders ratified the appointment of
Votes For Votes Against Abstentions 44,946,457 189,956 22,910
There were no broker non-votes regarding this proposal.
© Edgar Online, source
